Molecular Subtypes among Patients with Breast Cancer

IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL

Bahrain Medical Bulletin Pub Date : 2018-03-01 DOI:10.12816/0047462

L. Navsaria, Fatema Ali, R. Goswamy

引用次数: 1

Abstract

Result: Eighty-nine patients were included in the study. A total of one hundred and two patients were diagnosed with breast cancer based on biopsy results; thirteen patients were excluded due to the unknown stage and/or grade. The mean age was 53.9 years. The majority of cases were infiltrating ductal carcinoma (IDC), 82 (92%). The most common molecular subtype detected in the study was Luminal B (ER+, PR+, HER2+), 29 (32.6%) of the study population. Nine (10%) had an unknown grade, and 8 (8.9%) had unknown stage were excluded from the analysis.

查看原文本刊更多论文

癌症患者的分子亚型

结果：89名患者被纳入研究。根据活组织检查结果，共有102名患者被诊断为癌症；13名患者因分期和/或分级未知而被排除在外。平均年龄53.9岁。浸润性导管癌82例（92%）。研究中检测到的最常见的分子亚型是Luminal B（ER+、PR+、HER2+），占研究人群的29人（32.6%）。9人（10%）的分级未知，8人（8.9%）的分期未知被排除在分析之外。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Bahrain Medical Bulletin MEDICINE, GENERAL & INTERNAL-

CiteScore

0.60

自引率

50.00%

发文量

期刊介绍： The Bahrain Medical Bulletin is published every three months appearing in March, June, September and December. It is indexed in the World Health Organization Index Medicus for Eastern Mediterranean Region (IMEMRI), Extramed of the United Kingdom and International Serial Data System of France. Everything we publish is freely available online throughout the world, for you to read, download, copy, distribute, and use (with attribution) any way you wish. No permission required.